Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Z-360 + Gemcitabine in Advanced Pancreatic Cancer
NCT00288925Phase 2Completed
- Sponsor
- Zeria Pharmaceutical Co., Ltd.
- Start
- Sep 2005
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nastorazepide in pancreatic cancer (PC), sponsored by Zeria Pharmaceutical Co., Ltd.. Started Sep 2005; status: completed.
02
Drugs
nastorazepide
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00288925.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00288925.